About this trial
Earlier studies have shown a dose-dependent relationship between alcohol intake and incident atrial fibrillation (AF) as well as a causal link with several risk factors for AF such as hypertension, obesity and sleep apnea. However, the effect of drinking (alcohol) on post-ablation outcome such as arrhythmia recurrence, quality of life (QoL) and cognitive function in AF patients is unclear. Therefore, we aim to find the answer for a very frequently asked question, "is it safe to continue drinking alcohol (at the pre-ablation level) following catheter ablation OR should the intake be reduced for better outcome?", in this randomized trial.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
AF patients that regularly consume >5 alcoholic drink (*12 g of pure alcohol/drink)/week
Paroxysmal or persistent AF
First catheter ablation History of alcohol-induced arrhythmia
Willing to sign the written informed consent
Disqualifiers
Binge drinkers (alcohol dependence)
Non-drinkers
LVEF <35%
Psychiatric conditions
Trial design
Parallel
Treatments tested in this trial
Study arm
BehavioralParticipants will be asked to completely abstain from drinking or consume 2 or less drinks per week for 8 months following catheter ablation
Treatment groups
Trial outcomes
Primary outcomes
Arrhythmia recurrence
Arrhythmia recurrence across all AF types at 8 months after the ablation procedure, off- or on-antiarrhythmic drug (AAD)
Secondary outcomes
Change in QoL
Change in QoL measured by AFEQT survey at baseline and 6 months
Change in cognitive function
Change in cognitive function measured by MoCA survey
Arrhythmia burden
Arrhythmia burden at follow-up
Sponsors and contacts
Click on the lead sponsor to view all of their trials.